Previous Close | 158.85 |
Open | 159.25 |
Bid | 0.00 x 800 |
Ask | 166.45 x 900 |
Day's Range | 156.67 - 160.16 |
52 Week Range | 132.24 - 243.52 |
Volume | |
Avg. Volume | 1,605,891 |
Market Cap | 23.201B |
Beta (5Y Monthly) | 0.52 |
PE Ratio (TTM) | 25.65 |
EPS (TTM) | 6.15 |
Earnings Date | Jan 24, 2024 - Jan 29, 2024 |
Forward Dividend & Yield | 1.92 (1.22%) |
Ex-Dividend Date | Nov 08, 2023 |
1y Target Est | 178.38 |
Subscribe to Yahoo Finance Plus to view Fair Value for RMD
ResMed Inc (NYSE:RMD), a global leader in the development, manufacturing, and marketing of innovative medical products for the treatment and management of respiratory disorders, with a focus on sleep-disordered breathing, has recently witnessed a significant insider sell by its Chief Financial Officer (CFO), Brett Sandercock.
If we want to find a potential multi-bagger, often there are underlying trends that can provide clues. Firstly, we'd...
The company recently laid off 5% of its staff and stopped certain projects to lower operating costs.